Skip to main content

First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome

Familial Cancer volume 16, pages 57–66 (2017)Cite this article

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disorder characterized by the early onset of colorectal cancer (CRC) linked to germline defects in Mismatch Repair (MMR) genes. We present here, the first molecular study of the correlation between CRC and mutations occurring in these genes performed in twenty-one unrelated Algerian families. The presence of germline mutations in MMR genes, MLH1, MSH2 and MSH6 genes was tested by sequencing all exons plus adjacent intronic sequences and Multiplex ligand-dependent probe amplification (MLPA) for testing large genomic rearrangements. Pathogenic mutations were identified in 20 % of families with clinical suspicion on HNPCC. Two novel variants described for the first time in Algerian families were identified in MLH1, c.881_884delTCAGinsCATTCCT and a large deletion in MSH6 gene from a young onset of CRC. Moreover, the variants of MSH2 gene: c.942+3A>T, c.1030C>T, the most described ones, were also detected in Algerian families. Furthermore, the families HNPCC caused by MSH6 germline mutation may show an age of onset that is comparable to this of patients with MLH1 and MSH2 mutations. In this study, we confirmed that MSH2, MLH1, and MSH6 contribute to CRC susceptibility. This work represents the implementation of a diagnostic algorithm for the identification of Lynch syndrome patients in Algerian families.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Balaguer F, Castells A (2007) Identification of Lynch syndrome: are we close to the best strategy? Gastroenterology 133:353–355. doi:10.1053/j.gastro.2007.05.036

    Article  PubMed  Google Scholar 

  2. Vasen HFA, Möslein G, Alonso A et al (2010) Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 9:109–115. doi:10.1007/s10689-009-9291-3

    CAS  Article  PubMed  Google Scholar 

  3. Berginc G, Bracko M, Ravnik-Glavac M, Glavac D (2009) Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Fam Cancer 8:421–429. doi:10.1007/s10689-009-9258-4

    CAS  Article  PubMed  Google Scholar 

  4. Silva FCCD, Valentin MD, Ferreira FDO et al (2009) Mismatch repair genes in Lynch syndrome: a review. São Paulo Med J Rev Paul Med 127:46–51

    Article  Google Scholar 

  5. Peltomäki P (2014) Epigenetic mechanisms in the pathogenesis of Lynch syndrome. Clin Genet 85:403–412. doi:10.1111/cge.12349

    Article  PubMed  Google Scholar 

  6. Tutlewska K, Lubinski J, Kurzawski G (2013) Germline deletions in the EPCAM gene as a cause of Lynch syndrome—literature review. Hered Cancer Clin Pract 11:9. doi:10.1186/1897-4287-11-9

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ahmed S, El houari A (2013) 43 000 nouveaux cas de cancer enregistés. Algerie360.com. Information et Actualité sur l’Algérie. www.Algerie360.com/algerie/oncologie-43000-nouveaux-cas-de-Cancer-enregistés/. Accessed 7 May 2013

  8. Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Colon Rectum 34:424–425

    CAS  Article  Google Scholar 

  9. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116:1453–1456

    CAS  Article  PubMed  Google Scholar 

  10. Rodriguez-Bigas MA, Boland CR, Hamilton SR et al (1997) A National Cancer Institute Workshop on hereditary non-polyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758–1762

    CAS  Article  PubMed  Google Scholar 

  11. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. Thompson BA, Spurdle AB, Plazzer J-P et al (2014) Application of a 5-tiered scheme for standardized classification of 2360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet 46:107–115. doi:10.1038/ng.2854

    CAS  Article  PubMed  Google Scholar 

  13. Peltomäki P, Vasen H (2004) Mutations associated with HNPCC predisposition—update of ICG-HNPCC/INSiGHT mutation database. Markers 20:269–276

    Article  Google Scholar 

  14. Nakamura K, Banno K, Yanokura M et al (2014) Features of ovarian cancer in Lynch syndrome (review). Mol Clin Oncol 2:909–916. doi:10.3892/mco.2014.397

    PubMed  PubMed Central  Google Scholar 

  15. Liu B, Parsons RE, Hamilton SR et al (1994) hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 54:4590–4594

    CAS  PubMed  Google Scholar 

  16. Warden G, Harnett D, Green J et al (2013) A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity. Clin Genet 84:522–530. doi:10.1111/cge.12080

    CAS  Article  PubMed  Google Scholar 

  17. Pensotti V, Radice P, Presciuttini S et al (1997) Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes. Genes Chromosom Cancer 19:135–142

    CAS  Article  PubMed  Google Scholar 

  18. Valentin MD, da Silva FC, dos Santos EMM et al (2011) Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. Fam Cancer 10:641–647. doi:10.1007/s10689-011-9461-y

    CAS  Article  PubMed  Google Scholar 

  19. Chan TL, Yuen ST, Chung LP et al (1999) Frequent microsatellite instability and mismatch repair gene mutations in young Chinese patients with colorectal cancer. J Natl Cancer Inst 91:1221–1226

    CAS  Article  PubMed  Google Scholar 

  20. Froggatt NJ, Joyce JA, Davies R et al (1995) A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome. Lancet 345:727

    CAS  Article  PubMed  Google Scholar 

  21. Grandval P, Fabre AJ, Gaildrat P et al (2013) UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families. Database J Biol Databases Curation. doi:10.1093/database/bat036

    Google Scholar 

  22. Bartosova Z, Fridrichova I, Bujalkova M et al (2003) Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in Slovakia. Hum Mutat 21:449. doi:10.1002/humu.9127

    Article  PubMed  Google Scholar 

  23. Rey J-M, Noruzinia M, Brouillet J-P et al (2004) Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer. Cancer Genet Cytogenet 155:149–151. doi:10.1016/j.cancergencyto.2004.03.012

    CAS  Article  PubMed  Google Scholar 

  24. Auclair J, Busine MP, Navarro C et al (2006) Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 27:145–154. doi:10.1002/humu.20280

    CAS  Article  PubMed  Google Scholar 

  25. Chao EC, Velasquez JL, Witherspoon MSL et al (2008) Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat 29:852–860. doi:10.1002/humu.20735

    CAS  Article  PubMed  Google Scholar 

  26. Moussa SA-B, Moussa A, Kourda N et al (2011) Lynch syndrome in Tunisia: first description of clinical features and germline mutations. Int J Colorectal Dis 26:455–467. doi:10.1007/s00384-010-1129-9

    Article  PubMed  Google Scholar 

  27. Pistorius S, Görgens H, Plaschke J et al (2007) Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett 248:89–95. doi:10.1016/j.canlet.2006.06.002

    CAS  Article  PubMed  Google Scholar 

  28. Martínez-Bouzas C, Ojembarrena E, Beristain E et al (2007) High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country. Cancer Lett 255:295–299. doi:10.1016/j.canlet.2007.05.004

    Article  PubMed  Google Scholar 

  29. Bunyan DJ, Eccles DM, Sillibourne J et al (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155–1159. doi:10.1038/sj.bjc.6602121

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. Baudhuin LM, Ferber MJ, Winters JL et al (2005) Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients. Gastroenterology 129:846–854. doi:10.1053/j.gastro.2005.06.026

    CAS  Article  PubMed  Google Scholar 

  31. Klift H, Wijnen J, Wagner A et al (2005) Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosom Cancer 44:123–138. doi:10.1002/gcc.20219

    Article  PubMed  Google Scholar 

  32. Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda guidelines for hereditary non-polyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  33. Piñol V, Castells A, Andreu M et al (2005) Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary non-polyposis colorectal cancer. JAMA 293:1986–1994. doi:10.1001/jama.293.16.1986

    Article  PubMed  Google Scholar 

  34. Pérez-Cabornero L, Infante M, Velasco E et al (2013) Genotype-phenotype correlation in MMR mutation-positive families with Lynch syndrome. Int J Colorectal Dis 28:1195–1201. doi:10.1007/s00384-013-1685-x

    Article  PubMed  Google Scholar 

  35. Berends MJW, Wu Y, Sijmons RH et al (2002) Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 70:26–37. doi:10.1086/337944

    CAS  Article  PubMed  Google Scholar 

  36. Roncari B, Pedroni M, Maffei S et al (2007) Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. Clin Genet 72:230–237. doi:10.1111/j.1399-0004.2007.00856.x

    CAS  Article  PubMed  Google Scholar 

  37. Kolodner RD, Tytell JD, Schmeits JL et al (1999) Germ-line MSH6 mutations in colorectal cancer families. Cancer Res 59:5068–5074

    CAS  PubMed  Google Scholar 

  38. Vindigni SM, Kaz AM (2015) Universal screening of colorectal cancers for Lynch syndrome: challenges and opportunities. Dig Dis Sci. doi:10.1007/s10620-015-3964-6

    Google Scholar 

  39. Vasen HFA, Möslein G, Alonso A et al (2009) Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 9:109–115. doi:10.1007/s10689-009-9291-3

    Article  PubMed  Google Scholar 

  40. Kidambi TD, Blanco A, Myers M et al (2015) Selective versus universal screening for Lynch syndrome: a six-year clinical experience. Dig Dis Sci 60:2463–2469. doi:10.1007/s10620-014-3234-z

    Article  PubMed  Google Scholar 

  41. Thiel A, Heinonen M, Kantonen J et al (2013) BRAF mutation in sporadic colorectal cancer and Lynch syndrome. Virchows Arch Int J Pathol 463:613–621. doi:10.1007/s00428-013-1470-9

    CAS  Article  Google Scholar 

  42. Yamamoto H, Imai K (2015) Microsatellite instability: an update. Arch Toxicol 89:899–921. doi:10.1007/s00204-015-1474-0

    CAS  Article  PubMed  Google Scholar 

  43. Mange S, Bellcross C, Cragun D et al (2015) Creation of a network to promote universal screening for Lynch syndrome: the Lynch syndrome screening network. J Genet Couns 24:421–427. doi:10.1007/s10897-014-9770-z

    Article  PubMed  Google Scholar 

  44. Vasen HFA, Velthuizen ME, Kleibeuker JH et al (2016) Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry. Fam Cancer. doi:10.1007/s10689-016-9897-1

    Google Scholar 

  45. Hampel H (2016) Genetic counseling and cascade genetic testing in Lynch syndrome. Fam Cancer. doi:10.1007/s10689-016-9893-5

    Google Scholar 

Download references

Acknowledgments

We are grateful to the members of the HNPCC families for their willingness to participate in this study and for, providing the blood samples. We thank Mr. Eric Clauser, Mr. Nadim Hamzaoui, Dr.Marie-Odile North, Mrs. Michèle Nigou and Mrs. Magalie Dambrun, members of Oncogenetic Laboratory, Cochin, Paris for their precious collaboration and excellent technical assistance and all members of the Biology and Genetics Laboratory, Medical Oncology service, University Hospital Center, Constantine, Algeria. We thank Dr. Zitouni Mina, Genomics and Biotechnology, Canada for reading and editing this work.

Author information

Affiliations

  1. Department of Animal Biology, Faculty of Natural and Life Science, University 1, Mentouri Brothers, Constantine, Algeria

    H. Ziada-Bouchaar & D. Satta

  2. Laboratory of Biology and Molecular Genetics, Faculty of Medicine, University 3, Rabah Bitat, Constantine, Algeria

    H. Ziada-Bouchaar, K. Sifi, T. Filali, T. Hammada, D. Satta & N. Abadi

  3. Medical Oncology Service, University Hospital Center, Benbadis, Constantine, Algeria

    T. Filali

  4. Gastroenterology Service, University Hospital Center, Benbadis, Constantine, Algeria

    T. Hammada

Authors
  1. H. Ziada-Bouchaar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Sifi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Filali
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Hammada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Satta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Abadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Ziada-Bouchaar.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ziada-Bouchaar, H., Sifi, K., Filali, T. et al. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome. Familial Cancer 16, 57–66 (2017). https://doi.org/10.1007/s10689-016-9917-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-016-9917-1

Keywords

  • Algerian families
  • Hereditary non-polyposis colorectal cancer
  • Lynch syndrome
  • MLH1
  • MMR genes